Akeso Ebdarokimab Approved In China For Moderate - To - Severe Plaque Psoriasis
April 18 (Reuters) - Akeso Inc 9926.HK:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.